Rhythm Biosciences Limited (RHY.AX) - Stock Prices, Stock Peers & Analysis

Home
RHY.AX

Company Name	Rhythm Biosciences Limited
Symbol	RHY.AX
Currency	AUD
Price	0.1
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	25,259,700
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.042 - 0.23
Industry	Diagnostics & Research
Sector	Healthcare
CEO	Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD
Website	https://www.rhythmbio.com

An error occurred while fetching data.

About Rhythm Biosciences Limited

Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.